Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review

This study reports a patient developing TEN after the first dose of (BBIBP‐CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recove...

Descripción completa

Detalles Bibliográficos
Autores principales: Shakoei, Safoura, hadizadeh, Alireza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748221/
https://www.ncbi.nlm.nih.gov/pubmed/36523388
http://dx.doi.org/10.1002/ccr3.6726
_version_ 1784849780664434688
author Shakoei, Safoura
hadizadeh, Alireza
author_facet Shakoei, Safoura
hadizadeh, Alireza
author_sort Shakoei, Safoura
collection PubMed
description This study reports a patient developing TEN after the first dose of (BBIBP‐CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recovered within 14 days.
format Online
Article
Text
id pubmed-9748221
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97482212022-12-14 Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review Shakoei, Safoura hadizadeh, Alireza Clin Case Rep Case Report This study reports a patient developing TEN after the first dose of (BBIBP‐CorV). He developed numerous purpuric and dusky patches with flaccid bullae and areas of epidermal detachment covered more than 30% of the body area within 6 days. After treatment with dexamethasone and cyclosporin, he recovered within 14 days. John Wiley and Sons Inc. 2022-12-13 /pmc/articles/PMC9748221/ /pubmed/36523388 http://dx.doi.org/10.1002/ccr3.6726 Text en © 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Shakoei, Safoura
hadizadeh, Alireza
Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title_full Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title_fullStr Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title_full_unstemmed Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title_short Toxic epidermal necrosis following Sinopharm COVID‐19 vaccine (BBIBP‐CorV): A case report and literature review
title_sort toxic epidermal necrosis following sinopharm covid‐19 vaccine (bbibp‐corv): a case report and literature review
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748221/
https://www.ncbi.nlm.nih.gov/pubmed/36523388
http://dx.doi.org/10.1002/ccr3.6726
work_keys_str_mv AT shakoeisafoura toxicepidermalnecrosisfollowingsinopharmcovid19vaccinebbibpcorvacasereportandliteraturereview
AT hadizadehalireza toxicepidermalnecrosisfollowingsinopharmcovid19vaccinebbibpcorvacasereportandliteraturereview

Ejemplares similares